OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
71 hedge funds and large institutions have $246M invested in Oyster Point Pharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
71
Holding in Top 10
2
Calls
$60K
Puts
$14K
Top Buyers
| 1 | +$9.16M | |
| 2 | +$7.96M | |
| 3 | +$1.22M | |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$971K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$631K |
Top Sellers
| 1 | -$3.81M | |
| 2 | -$3.32M | |
| 3 | -$2.19M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$1.69M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.54M |